Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer

American Journal of Surgery

Volumn 199, Issue 3, 2010, Pages 315-318

  Cook, Mackenzie R ^a   Luo, Jie ^a   Ndiaye, Mary ^a   Chen, Herbert ^a   Kunnimalaiyaan, Muthusamy ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Achaete scute complex like 1; Medullary thyroid cancer; Neuroendocrine tumor; Phosphorylated ERK1 2; Xanthohumol

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAF PROTEIN; TRANSCRIPTION FACTOR MASH1; XANTHOHUMOL;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; DRUG INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYPOTHESIS; MEDULLARY THYROID CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THYROID CANCER; WESTERN BLOTTING;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL PROLIFERATION; CELLS, CULTURED; DRUG SCREENING ASSAYS, ANTITUMOR; FLAVONOIDS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROPIOPHENONES; THYROID NEOPLASMS;

EID: 77649300540     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.08.034     Document Type: Article

References (20)

1. Chen H., Roberts J.R., Ball D.W., et al. Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. Ann Surg 227 (1998) 887-895
2. Sippel R.S., Kunnimalaiyaan M., and Chen H. Current management of medullary thyroid cancer. Oncologist 13 (2008) 539-547
3. Hahm J.R., Lee M.S., Min Y.K., et al. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 11 (2001) 73-80
4. Moley J.F., Lairmore T.C., and Phay J.E. Hereditary endocrinopathies. Curr Probl Surg 36 (1999) 653-762
5. Kebebew E., Kikuchi S., Duh Q.Y., et al. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. Arch Surg 135 (2000) 895-901
6. Chen H., Thiagalingam A., Chopra H., et al. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HE'S-1) directly represses achaete-scute homolog-1 expression. Proc Natl Acad Sci U S A 94 (1997) 5355-5360
7. Sippel R.S., Carpenter J.E., Kunnimalaiyaan M., et al. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. Surgery 134 (2003) 866-871
8. Borges M., Linnoila R.I., van de Velde H.J., et al. An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 386 (1997) 852-855
9. Chen H., Biel M.A., Borges M.W., et al. Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions. Cell Growth Differ 8 (1997) 677-686
10. Lanigan T.M., DeRaad S.K., and Russo A.F. Requirement of the MASH-1 transcription factor for neuroendocrine differentiation of thyroid C cells. J Neurobiol 34 (1998) 126-134
11. Dhillon A.S., Hagan S., Rath O., et al. Map kinase signalling pathways in cancer. Oncogene 26 (2007) 3279-3290
12. Vaccaro A., Chen H., and Kunnimalaiyaan M. In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer. Anticancer Drugs 17 (2006) 849-853
13. Dell'Eva R., Ambrosini C., Vannini N., et al. AKT/NF-κB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies. Cancer 110 (2007) 2007-2011
14. Delmulle L., Bellahcene A., Dhooge W., et al. Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine 13 (2006) 732-734
15. Ho Y.C., Liu C.H., Chen C.N., et al. Inhibitory effects of xanthohumol from hops (Humulus lupulus L.) on human hepatocellular carcinoma cell lines. Phytother Res 22 (2008) 1465-1468
16. Koo J.H., Kim H.T., Yoon H.Y., et al. Effect of xanthohumol on melanogenesis in B16 melanoma cells. Exp Mol Med 40 (2008) 313-319
17. Kunnimalaiyaan M., Vaccaro A.M., Ndiaye M.A., et al. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells. J Biol Chem 281 (2006) 39819-39830
18. Greenblatt D.Y., Vaccaro A.M., Jaskula-Sztul R., et al. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist 12 (2007) 942-951
19. Chen H., Kunnimalaiyaan M., and Van Gompel J.J. Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1. Thyroidology 15 (2005) 511-521
20. Udelsman R., and Chen H. The current management of thyroid cancer. Adv Surg 33 (1999) 1-27